Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study
Completed
Conditions studied: Neovascular Age-related Macular Degeneration
In brief
The study will enroll up to 30 AMD patients diagnosed with NV-AMD in at least one eye at the time of enrollment. At the Study Visit, fluid must be present in at least one eye of the subjects. If only one eye qualifies for enrollment, that will be assigned as the study eye. If both eyes are eligible, the study eye will be assigned according to a randomization schedule. Only one eye of each subject will be enrolled in the study. All subjects will be enrolled at 1 site in the United States. Subjects must meet all inclusion and no exclusion criteria.
Key facts
- Study ID
- NCT05281042
- Run by
- Notal Vision Inc.
- People needed
- 20
- Starts
- 2021-09-13
- Expected to finish
- 2022-01-05
- Last updated by the study team
- 2022-04-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ability to speak, read and understand English.
- Ability to understand and agree to contents of informed consent in writing or verbal.
- Adult diagnosed with NV-AMD in at least one eye based on the subject's medical record.
- Fluid presence in the study eye per the PI review of Screening commercial OCT.
- Best corrected Visual Acuity of 20/320 or better in the study eye.
- Available and willing to conduct self-scanning in the office
You may not qualify if…
- Any other retinal disease requiring steroidal or anti-VEGF injections.
- Dilated pupils
Where it is running
- Elman Retina Group — Glen Burnie, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.